Aurobindo Pharma gets FDA nod for Sertraline Hydrochloride
MUMBAI, Nov 7 (Reuters) - Aurobindo Pharma Ltd (ARBN.BO: Quote, Profile, Research) on Friday said it got final approval from the U.S. Food and Drug Administration to make and market a 20 mg dose of Sertraline Hydrochloride.
Sertraline is the generic equivalent of Pfizer's (PFE.N: Quote, Profile, Research) Zoloft used for the treatment of depressive disorder in adults.
(Reporting by Aniruddha Basu; Editing by Prem Udayabhanu)
© Thomson Reuters 2010 All rights reserved
Economy seen growing at 7.2 pct in FY10 - govt
The forecast reinforces the possibility that the government may start to unwind its fiscal stimulus in the budget. Full Article
Greek crisis sets euro zone enlargement back
The Greek debt crisis has dealt a setback to prospects of enlarging the euro zone by highlighting the difficulties of managing the single currency area. Full Article
India
US
UK
